Richard Close's Stock Ratings

Canaccord Genuity Analyst

Richard Close is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024

Overall Average Return

-10.6%

Smart Score

44.7%

Overall Average Return Percentile

20th

Number of Ratings

68
Buy NowGet Alert
06/28/2024ACCDBuy Now
Accolade
$3.65256.16%$16 → $13MaintainsBuyGet Alert
06/21/2024SHCRBuy Now
Sharecare
$1.365.15%$2 → $1.43DowngradeBuy → HoldGet Alert
05/31/2024PHRBuy Now
Phreesia
$21.2060.38%$37 → $34MaintainsBuyGet Alert
05/21/2024SHCRBuy Now
Sharecare
$1.3647.06%$2 → $2MaintainsBuyGet Alert
05/21/2024HCATBuy Now
Health Catalyst
$6.3972.14%$11 → $11MaintainsBuyGet Alert
05/17/2024QIPTBuy Now
Quipt Home Medical
$3.22148.45%$9 → $8MaintainsBuyGet Alert
05/10/2024PRVABuy Now
Privia Health Gr
$17.3849.6%$37 → $26MaintainsBuyGet Alert
05/10/2024PGNYBuy Now
Progyny
$28.3830.37%$46 → $37MaintainsBuyGet Alert
05/10/2024EVHBuy Now
Evolent Health
$18.90116.93%$44 → $41MaintainsBuyGet Alert
05/09/2024RCMBuy Now
R1 RCM
$12.5619.43%$16 → $15MaintainsBuyGet Alert
05/09/2024DCGOBuy Now
DocGo
$3.0961.81%$9 → $5MaintainsBuyGet Alert
05/08/2024PINCBuy Now
Premier
$18.6712.48%$27 → $21DowngradeBuy → HoldGet Alert
04/26/2024TDOCBuy Now
Teladoc Health
$9.78155.62%$28 → $25MaintainsBuyGet Alert
04/26/2024ACCDBuy Now
Accolade
$3.65338.36%$18 → $16MaintainsBuyGet Alert
04/11/2024DCGOBuy Now
DocGo
$3.09191.26%$10 → $9MaintainsBuyGet Alert
03/28/2024EVHBuy Now
Evolent Health
$18.90132.8%$45 → $44MaintainsBuyGet Alert
03/20/2024RCMBuy Now
R1 RCM
$12.5627.39%$17 → $16MaintainsBuyGet Alert
03/19/2024PRVABuy Now
Privia Health Gr
$17.38112.89%$41 → $37MaintainsBuyGet Alert
03/15/2024PHRBuy Now
Phreesia
$21.2074.53%$36 → $37MaintainsBuyGet Alert
02/29/2024DCGOBuy Now
DocGo
$3.09223.62%$11 → $10MaintainsBuyGet Alert
02/26/2024LAMRBuy Now
Lamar Advertising
$119.53-8.81%$92 → $109MaintainsNeutralGet Alert
02/23/2024HCATBuy Now
Health Catalyst
$6.3972.14%$12 → $11MaintainsBuyGet Alert
02/23/2024EVHBuy Now
Evolent Health
$18.90138.1%$47 → $45MaintainsBuyGet Alert
02/21/2024TDOCBuy Now
Teladoc Health
$9.78186.3%$34 → $28MaintainsBuyGet Alert
12/07/2023RCMBuy Now
R1 RCM
$12.5635.35% → $17ReiteratesBuy → BuyGet Alert
10/05/2023ACCDBuy Now
Accolade
$3.65365.75%$18 → $17MaintainsBuyGet Alert
09/27/2023PGNYBuy Now
Progyny
$28.3862.09% → $46Initiates → BuyGet Alert
09/07/2023PHRBuy Now
Phreesia
$21.20102.83%$46 → $43MaintainsBuyGet Alert
09/05/2023DOCSBuy Now
Doximity
$27.9717.98%$40 → $33MaintainsBuyGet Alert
09/01/2023PHRBuy Now
Phreesia
$21.20116.98% → $46ReiteratesBuy → BuyGet Alert
08/29/2023HCATBuy Now
Health Catalyst
$6.39119.09%$16 → $14MaintainsBuyGet Alert
08/23/2023PINCBuy Now
Premier
$18.6760.69%$38 → $30MaintainsBuyGet Alert
06/21/2023DCGOBuy Now
DocGo
$3.09320.71% → $13ReiteratesBuy → BuyGet Alert
06/14/2023QIPTBuy Now
Quipt Home Medical
$3.22241.61% → $11Assumes → BuyGet Alert
06/07/2023DOCSBuy Now
Doximity
$27.9743.01% → $40ReiteratesBuy → BuyGet Alert
05/17/2023DOCSBuy Now
Doximity
$27.9743.01%$41 → $40MaintainsBuyGet Alert
05/10/2023AHCOBuy Now
AdaptHealth
$10.0070%$22 → $17MaintainsBuyGet Alert
04/28/2023ACCDBuy Now
Accolade
$3.65393.15%$14 → $18MaintainsBuyGet Alert
03/06/2023TDOCBuy Now
Teladoc Health
$9.78268.1%$40 → $36MaintainsBuyGet Alert
03/06/2023CLOVBuy Now
Clover Health Investments
$1.24141.94%$4 → $3MaintainsBuyGet Alert
02/27/2023LAMRBuy Now
Lamar Advertising
$119.53-7.97%$100 → $110MaintainsNeutralGet Alert
02/22/2023HSTMBuy Now
HealthStream
$27.90-6.81%$23 → $26MaintainsHoldGet Alert
02/17/2023RCMBuy Now
R1 RCM
$12.5667.2%$17 → $21MaintainsBuyGet Alert
02/10/2023DOCSBuy Now
Doximity
$27.9746.59%$42 → $41MaintainsBuyGet Alert
01/05/2023RCMBuy Now
R1 RCM
$12.5611.46% → $14Initiates → BuyGet Alert
11/11/2022SHCRBuy Now
Sharecare
$1.36120.59%$4 → $3MaintainsBuyGet Alert
11/11/2022PRVABuy Now
Privia Health Gr
$17.38147.41%$50 → $43MaintainsBuyGet Alert
11/11/2022BBLNBuy Now
Babylon Holdings
——$100 → $50MaintainsBuyGet Alert
10/12/2022EVHBuy Now
Evolent Health
$18.90153.97%$55 → $48MaintainsBuyGet Alert
10/03/2022ACCDBuy Now
Accolade
$3.65310.96%$12 → $15MaintainsBuyGet Alert
09/08/2022PHRBuy Now
Phreesia
$21.2069.81%$37 → $36MaintainsBuyGet Alert
08/25/2022PRVABuy Now
Privia Health Gr
$17.38187.69%$45 → $50MaintainsBuyGet Alert
08/17/2022PINCBuy Now
Premier
$18.67146.38%$44 → $46MaintainsBuyGet Alert
08/17/2022BBLNBuy Now
Babylon Holdings
——$125 → $100MaintainsBuyGet Alert
08/05/2022DOCSBuy Now
Doximity
$27.9750.16%$47 → $42MaintainsBuyGet Alert
07/01/2022ACCDBuy Now
Accolade
$3.65228.77%$17 → $12MaintainsBuyGet Alert
05/13/2022PRVABuy Now
Privia Health Gr
$17.3866.86%$44 → $29MaintainsBuyGet Alert
05/09/2022EVHBuy Now
Evolent Health
$18.90138.1%$40 → $45MaintainsBuyGet Alert
04/28/2022TDOCBuy Now
Teladoc Health
$9.78411.25%$112 → $50MaintainsBuyGet Alert
03/31/2022PHRBuy Now
Phreesia
$21.20131.13%$81 → $49MaintainsBuyGet Alert
03/24/2022PRVABuy Now
Privia Health Gr
$17.38153.16%$50 → $44MaintainsBuyGet Alert
03/24/2022CNVYBuy Now
Convey Health Solutions
——$18 → $14MaintainsBuyGet Alert
03/09/2022OTRKBuy Now
Ontrak
$0.201150.63%$78 → $15MaintainsHoldGet Alert
03/02/2022HCATBuy Now
Health Catalyst
$6.39447.73%$62 → $35MaintainsBuyGet Alert
02/02/2022CLOVBuy Now
Clover Health Investments
$1.24383.87% → $6Initiates → BuyGet Alert
12/21/2021DCGOBuy Now
DocGo
$3.09320.71% → $13Initiates → BuyGet Alert
12/02/2021BBLNBuy Now
Babylon Holdings
———Initiates → BuyGet Alert
11/23/2021TDOCBuy Now
Teladoc Health
$9.781535.99%—MaintainsBuyGet Alert

Recent Analyst Stock Rating News

6 Analysts Assess R1 RCM: What You Need To Know
Why Are Altimmune Shares Trading Lower Wednesday?
Altimmune shares are experiencing significant movement lower following the unexpected passing of Richard Eisenstadt, the company's Chief Financial Officer.
Key Takeaways From Sharecare Analyst Ratings
Netflix's Immersive Experiences May Push Them 'Off Their Course,' IMAX CEO Raises Alarm: 'Hard To Do Things That Aren't Your Core Competencies'
Gelfond's comments appeared after Netflix recently announced that the first two immersive venues, dubbed "Netflix House," will open by 2025 at King of Prussia in Pennsylvania and Galleria Dallas, Texas.
Former United Airlines CEO Slams Boeing's 'Lack Of Trust' As CEO Dave Calhoun Faces Senate Heat
Munoz's comments highlight the challenges Boeing faces amid its leadership crisis.
Virgin Orbit Fake Offer: SEC Sues Texas Man For $20M Bid
The SEC has sued Matthew Brown for an alleged $200 million fraudulent offer to rescue Virgin Orbit, accusing him of fabricating credentials and a bank statement. Virgin Orbit terminated discussions due to credibility issues.
Vermont Lawmakers Overturn Gov.'s Veto And Approve Measure To Set Up Safe Drug-Consumption Sites In Most Populous City
Vermont became the third state this week to green-light safe consumption sites where those using prohibited drugs could be allowed to do it in a medically supervised environment. The lawmakers approved a safe consumption site (SCS) pilot on Monday, despite strong opposition from Gov. Phil Scott (R).The governor earlier vetoed H.72, which sought to both legalize and fund a facility based in the city of Burlington as a safe consumption site with $1.1 million from settlements with pharmaceutical companies.
FedEx Plans Up To 2,000 Job Cuts To Slash Costs In Europe Shakeup
FedEx is set to reduce its workforce by 1,700 to 2,000 positions across Europe as part of a strategic initiative to streamline operations and decrease structural costs.
Critical Insights From R1 RCM Analyst Ratings: What You Need To Know
Health Catalyst Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.
Get Started for Free